The University of Chicago Header Logo

Connection

Mark W. Lingen to Combined Modality Therapy

This is a "connection" page, showing publications Mark W. Lingen has written about Combined Modality Therapy.
Connection Strength

0.054
  1. New therapeutic strategies for the treatment and prevention of head and neck cancer. Expert Opin Investig Drugs. 2000 Dec; 9(12):2855-72.
    View in: PubMed
    Score: 0.036
  2. Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol. 2010 Jul 10; 28(20):3336-43.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.